The new Genes and Human Disease Research Program will broaden OMRF’s investigation into genetic mechanisms in various diseases.
The trio of scientists assumed their new positions at the foundation Nov. 1, bringing the total number of OMRF senior scientists to 49.
The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.
The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
The grant will help two new scientists establish labs at OMRF.